Skip to main content

UBS Group AG

Position in VTVT — vTv Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in VTVT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$81,888
-$141,634 QoQ
Shares Held
2,175
-61.4% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 45 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. VTVT ranks #371 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VTVT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $81,888 2,175
2026-03-31 $223,522 5,636
2025-12-31 $66,703 1,668
2025-09-30 $69,348 2,970
2025-06-30 $42,705 2,847
2025-03-31 $69,971 4,040
2024-12-31 $103,732 7,512
2024-09-30 $11,747 866
2024-06-30 $73,818 4,180
2024-03-31 $34,283 1,457
2023-03-31 $774 959
2022-12-31 $5,168 7,795
2022-09-30 $13,347 13,760
2021-12-31 $16,807 16,892
2021-06-30 $24,190 10,610
2021-03-31 $11,045 3,917
2020-12-31 $17,545 9,433
2020-09-30 $15,142 8,555
2020-06-30 $9,722 4,321
2020-03-31 $1,910 1,000